Global iPSC Therapy Market Growth (Status and Outlook) 2026-2032
The global iPSC Therapy market size is predicted to grow from US$ 877 million in 2025 to US$ 1853 million in 2032; it is expected to grow at a CAGR of 11.7% from 2026 to 2032.
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
LPI (LP Information)' newest research report, the ?iPSC Therapy Industry Forecast? looks at past sales and reviews total world iPSC Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC Therapy sales for 2026 through 2032. With iPSC Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC Therapy industry.
This Insight Report provides a comprehensive analysis of the global iPSC Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global iPSC Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
LPI (LP Information)' newest research report, the ?iPSC Therapy Industry Forecast? looks at past sales and reviews total world iPSC Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC Therapy sales for 2026 through 2032. With iPSC Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC Therapy industry.
This Insight Report provides a comprehensive analysis of the global iPSC Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on iPSC Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global iPSC Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Human iPSCs
- Mouse iPSCs
- Hospitals
- Biotech Firms
- Research Institutes
- Neural Cells
- Cardiac Cells
- Retinal Cells
- Immune Cells
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fujifilm
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma Inc
- Fate Therapeutics, Inc
- Pluricell Biotech
- Cell Inspire Biotechnology
- ReproCELL
- Thermo Fisher Scientific
- Sartorius
- Bio-techne
- Lonza
- Takara Bio
- STEMCELL Technologies
- Fujifilm
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC Therapy Market Size (2021-2032)
2.1.2 iPSC Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for iPSC Therapy by Country/Region (2021, 2025 & 2032)
2.2 iPSC Therapy Segment by Type
2.2.1 Human iPSCs
2.2.2 Mouse iPSCs
2.2.3 iPSC Therapy Market Size by Type
2.2.3.1 iPSC Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global iPSC Therapy Market Size Market Share by Type (2021-2026)
2.3 iPSC Therapy Segment by End User
2.3.1 Hospitals
2.3.2 Biotech Firms
2.3.3 Research Institutes
2.3.4 iPSC Therapy Market Size by End User
2.3.4.1 iPSC Therapy Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.3.4.2 Global iPSC Therapy Market Size Market Share by End User (2021-2026)
2.4 iPSC Therapy Segment by Cell Type
2.4.1 Neural Cells
2.4.2 Cardiac Cells
2.4.3 Retinal Cells
2.4.4 Immune Cells
2.4.5 iPSC Therapy Market Size by Cell Type
2.4.5.1 iPSC Therapy Market Size CAGR by Cell Type (2021 VS 2025 VS 2032)
2.4.5.2 Global iPSC Therapy Market Size Market Share by Cell Type (2021-2026)
2.5 iPSC Therapy Segment by Application
2.5.1 Academic Research
2.5.2 Drug Development and Discovery
2.5.3 Toxicity Screening
2.5.4 Regenerative Medicine
2.5.5 Others
2.5.6 iPSC Therapy Market Size by Application
2.5.6.1 iPSC Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global iPSC Therapy Market Size Market Share by Application (2021-2026)
3 IPSC THERAPY MARKET SIZE BY PLAYER
3.1 iPSC Therapy Market Size Market Share by Player
3.1.1 Global iPSC Therapy Revenue by Player (2021-2026)
3.1.2 Global iPSC Therapy Revenue Market Share by Player (2021-2026)
3.2 Global iPSC Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IPSC THERAPY BY REGION
4.1 iPSC Therapy Market Size by Region (2021-2026)
4.2 Global iPSC Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC Therapy Market Size Growth (2021-2026)
4.4 APAC iPSC Therapy Market Size Growth (2021-2026)
4.5 Europe iPSC Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa iPSC Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas iPSC Therapy Market Size by Country (2021-2026)
5.2 Americas iPSC Therapy Market Size by Type (2021-2026)
5.3 Americas iPSC Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC Therapy Market Size by Region (2021-2026)
6.2 APAC iPSC Therapy Market Size by Type (2021-2026)
6.3 APAC iPSC Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe iPSC Therapy Market Size by Country (2021-2026)
7.2 Europe iPSC Therapy Market Size by Type (2021-2026)
7.3 Europe iPSC Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC Therapy by Region (2021-2026)
8.2 Middle East & Africa iPSC Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa iPSC Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IPSC THERAPY MARKET FORECAST
10.1 Global iPSC Therapy Forecast by Region (2027-2032)
10.1.1 Global iPSC Therapy Forecast by Region (2027-2032)
10.1.2 Americas iPSC Therapy Forecast
10.1.3 APAC iPSC Therapy Forecast
10.1.4 Europe iPSC Therapy Forecast
10.1.5 Middle East & Africa iPSC Therapy Forecast
10.2 Americas iPSC Therapy Forecast by Country (2027-2032)
10.2.1 United States Market iPSC Therapy Forecast
10.2.2 Canada Market iPSC Therapy Forecast
10.2.3 Mexico Market iPSC Therapy Forecast
10.2.4 Brazil Market iPSC Therapy Forecast
10.3 APAC iPSC Therapy Forecast by Region (2027-2032)
10.3.1 China iPSC Therapy Market Forecast
10.3.2 Japan Market iPSC Therapy Forecast
10.3.3 Korea Market iPSC Therapy Forecast
10.3.4 Southeast Asia Market iPSC Therapy Forecast
10.3.5 India Market iPSC Therapy Forecast
10.3.6 Australia Market iPSC Therapy Forecast
10.4 Europe iPSC Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market iPSC Therapy Forecast
10.4.2 France Market iPSC Therapy Forecast
10.4.3 UK Market iPSC Therapy Forecast
10.4.4 Italy Market iPSC Therapy Forecast
10.4.5 Russia Market iPSC Therapy Forecast
10.5 Middle East & Africa iPSC Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market iPSC Therapy Forecast
10.5.2 South Africa Market iPSC Therapy Forecast
10.5.3 Israel Market iPSC Therapy Forecast
10.5.4 Turkey Market iPSC Therapy Forecast
10.6 Global iPSC Therapy Forecast by Type (2027-2032)
10.7 Global iPSC Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market iPSC Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Fujifilm
11.1.1 Fujifilm Company Information
11.1.2 Fujifilm iPSC Therapy Product Offered
11.1.3 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Fujifilm Main Business Overview
11.1.5 Fujifilm Latest Developments
11.2 Ncardia
11.2.1 Ncardia Company Information
11.2.2 Ncardia iPSC Therapy Product Offered
11.2.3 Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ncardia Main Business Overview
11.2.5 Ncardia Latest Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Information
11.3.2 Sumitomo Dainippon Pharma iPSC Therapy Product Offered
11.3.3 Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sumitomo Dainippon Pharma Main Business Overview
11.3.5 Sumitomo Dainippon Pharma Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc iPSC Therapy Product Offered
11.4.3 Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Information
11.5.2 Fate Therapeutics, Inc iPSC Therapy Product Offered
11.5.3 Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fate Therapeutics, Inc Main Business Overview
11.5.5 Fate Therapeutics, Inc Latest Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Information
11.6.2 Pluricell Biotech iPSC Therapy Product Offered
11.6.3 Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pluricell Biotech Main Business Overview
11.6.5 Pluricell Biotech Latest Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Information
11.7.2 Cell Inspire Biotechnology iPSC Therapy Product Offered
11.7.3 Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cell Inspire Biotechnology Main Business Overview
11.7.5 Cell Inspire Biotechnology Latest Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Information
11.8.2 ReproCELL iPSC Therapy Product Offered
11.8.3 ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ReproCELL Main Business Overview
11.8.5 ReproCELL Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific iPSC Therapy Product Offered
11.9.3 Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Sartorius
11.10.1 Sartorius Company Information
11.10.2 Sartorius iPSC Therapy Product Offered
11.10.3 Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Sartorius Main Business Overview
11.10.5 Sartorius Latest Developments
11.11 Bio-techne
11.11.1 Bio-techne Company Information
11.11.2 Bio-techne iPSC Therapy Product Offered
11.11.3 Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bio-techne Main Business Overview
11.11.5 Bio-techne Latest Developments
11.12 Lonza
11.12.1 Lonza Company Information
11.12.2 Lonza iPSC Therapy Product Offered
11.12.3 Lonza iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Lonza Main Business Overview
11.12.5 Lonza Latest Developments
11.13 Takara Bio
11.13.1 Takara Bio Company Information
11.13.2 Takara Bio iPSC Therapy Product Offered
11.13.3 Takara Bio iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Takara Bio Main Business Overview
11.13.5 Takara Bio Latest Developments
11.14 STEMCELL Technologies
11.14.1 STEMCELL Technologies Company Information
11.14.2 STEMCELL Technologies iPSC Therapy Product Offered
11.14.3 STEMCELL Technologies iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 STEMCELL Technologies Main Business Overview
11.14.5 STEMCELL Technologies Latest Developments
11.15 Fujifilm
11.15.1 Fujifilm Company Information
11.15.2 Fujifilm iPSC Therapy Product Offered
11.15.3 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Fujifilm Main Business Overview
11.15.5 Fujifilm Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC Therapy Market Size (2021-2032)
2.1.2 iPSC Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for iPSC Therapy by Country/Region (2021, 2025 & 2032)
2.2 iPSC Therapy Segment by Type
2.2.1 Human iPSCs
2.2.2 Mouse iPSCs
2.2.3 iPSC Therapy Market Size by Type
2.2.3.1 iPSC Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global iPSC Therapy Market Size Market Share by Type (2021-2026)
2.3 iPSC Therapy Segment by End User
2.3.1 Hospitals
2.3.2 Biotech Firms
2.3.3 Research Institutes
2.3.4 iPSC Therapy Market Size by End User
2.3.4.1 iPSC Therapy Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.3.4.2 Global iPSC Therapy Market Size Market Share by End User (2021-2026)
2.4 iPSC Therapy Segment by Cell Type
2.4.1 Neural Cells
2.4.2 Cardiac Cells
2.4.3 Retinal Cells
2.4.4 Immune Cells
2.4.5 iPSC Therapy Market Size by Cell Type
2.4.5.1 iPSC Therapy Market Size CAGR by Cell Type (2021 VS 2025 VS 2032)
2.4.5.2 Global iPSC Therapy Market Size Market Share by Cell Type (2021-2026)
2.5 iPSC Therapy Segment by Application
2.5.1 Academic Research
2.5.2 Drug Development and Discovery
2.5.3 Toxicity Screening
2.5.4 Regenerative Medicine
2.5.5 Others
2.5.6 iPSC Therapy Market Size by Application
2.5.6.1 iPSC Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.6.2 Global iPSC Therapy Market Size Market Share by Application (2021-2026)
3 IPSC THERAPY MARKET SIZE BY PLAYER
3.1 iPSC Therapy Market Size Market Share by Player
3.1.1 Global iPSC Therapy Revenue by Player (2021-2026)
3.1.2 Global iPSC Therapy Revenue Market Share by Player (2021-2026)
3.2 Global iPSC Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IPSC THERAPY BY REGION
4.1 iPSC Therapy Market Size by Region (2021-2026)
4.2 Global iPSC Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC Therapy Market Size Growth (2021-2026)
4.4 APAC iPSC Therapy Market Size Growth (2021-2026)
4.5 Europe iPSC Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa iPSC Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas iPSC Therapy Market Size by Country (2021-2026)
5.2 Americas iPSC Therapy Market Size by Type (2021-2026)
5.3 Americas iPSC Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC Therapy Market Size by Region (2021-2026)
6.2 APAC iPSC Therapy Market Size by Type (2021-2026)
6.3 APAC iPSC Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe iPSC Therapy Market Size by Country (2021-2026)
7.2 Europe iPSC Therapy Market Size by Type (2021-2026)
7.3 Europe iPSC Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC Therapy by Region (2021-2026)
8.2 Middle East & Africa iPSC Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa iPSC Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IPSC THERAPY MARKET FORECAST
10.1 Global iPSC Therapy Forecast by Region (2027-2032)
10.1.1 Global iPSC Therapy Forecast by Region (2027-2032)
10.1.2 Americas iPSC Therapy Forecast
10.1.3 APAC iPSC Therapy Forecast
10.1.4 Europe iPSC Therapy Forecast
10.1.5 Middle East & Africa iPSC Therapy Forecast
10.2 Americas iPSC Therapy Forecast by Country (2027-2032)
10.2.1 United States Market iPSC Therapy Forecast
10.2.2 Canada Market iPSC Therapy Forecast
10.2.3 Mexico Market iPSC Therapy Forecast
10.2.4 Brazil Market iPSC Therapy Forecast
10.3 APAC iPSC Therapy Forecast by Region (2027-2032)
10.3.1 China iPSC Therapy Market Forecast
10.3.2 Japan Market iPSC Therapy Forecast
10.3.3 Korea Market iPSC Therapy Forecast
10.3.4 Southeast Asia Market iPSC Therapy Forecast
10.3.5 India Market iPSC Therapy Forecast
10.3.6 Australia Market iPSC Therapy Forecast
10.4 Europe iPSC Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market iPSC Therapy Forecast
10.4.2 France Market iPSC Therapy Forecast
10.4.3 UK Market iPSC Therapy Forecast
10.4.4 Italy Market iPSC Therapy Forecast
10.4.5 Russia Market iPSC Therapy Forecast
10.5 Middle East & Africa iPSC Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market iPSC Therapy Forecast
10.5.2 South Africa Market iPSC Therapy Forecast
10.5.3 Israel Market iPSC Therapy Forecast
10.5.4 Turkey Market iPSC Therapy Forecast
10.6 Global iPSC Therapy Forecast by Type (2027-2032)
10.7 Global iPSC Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market iPSC Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Fujifilm
11.1.1 Fujifilm Company Information
11.1.2 Fujifilm iPSC Therapy Product Offered
11.1.3 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Fujifilm Main Business Overview
11.1.5 Fujifilm Latest Developments
11.2 Ncardia
11.2.1 Ncardia Company Information
11.2.2 Ncardia iPSC Therapy Product Offered
11.2.3 Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ncardia Main Business Overview
11.2.5 Ncardia Latest Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Information
11.3.2 Sumitomo Dainippon Pharma iPSC Therapy Product Offered
11.3.3 Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sumitomo Dainippon Pharma Main Business Overview
11.3.5 Sumitomo Dainippon Pharma Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc iPSC Therapy Product Offered
11.4.3 Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Information
11.5.2 Fate Therapeutics, Inc iPSC Therapy Product Offered
11.5.3 Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fate Therapeutics, Inc Main Business Overview
11.5.5 Fate Therapeutics, Inc Latest Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Information
11.6.2 Pluricell Biotech iPSC Therapy Product Offered
11.6.3 Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pluricell Biotech Main Business Overview
11.6.5 Pluricell Biotech Latest Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Information
11.7.2 Cell Inspire Biotechnology iPSC Therapy Product Offered
11.7.3 Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cell Inspire Biotechnology Main Business Overview
11.7.5 Cell Inspire Biotechnology Latest Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Information
11.8.2 ReproCELL iPSC Therapy Product Offered
11.8.3 ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 ReproCELL Main Business Overview
11.8.5 ReproCELL Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific iPSC Therapy Product Offered
11.9.3 Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Sartorius
11.10.1 Sartorius Company Information
11.10.2 Sartorius iPSC Therapy Product Offered
11.10.3 Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Sartorius Main Business Overview
11.10.5 Sartorius Latest Developments
11.11 Bio-techne
11.11.1 Bio-techne Company Information
11.11.2 Bio-techne iPSC Therapy Product Offered
11.11.3 Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bio-techne Main Business Overview
11.11.5 Bio-techne Latest Developments
11.12 Lonza
11.12.1 Lonza Company Information
11.12.2 Lonza iPSC Therapy Product Offered
11.12.3 Lonza iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Lonza Main Business Overview
11.12.5 Lonza Latest Developments
11.13 Takara Bio
11.13.1 Takara Bio Company Information
11.13.2 Takara Bio iPSC Therapy Product Offered
11.13.3 Takara Bio iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Takara Bio Main Business Overview
11.13.5 Takara Bio Latest Developments
11.14 STEMCELL Technologies
11.14.1 STEMCELL Technologies Company Information
11.14.2 STEMCELL Technologies iPSC Therapy Product Offered
11.14.3 STEMCELL Technologies iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 STEMCELL Technologies Main Business Overview
11.14.5 STEMCELL Technologies Latest Developments
11.15 Fujifilm
11.15.1 Fujifilm Company Information
11.15.2 Fujifilm iPSC Therapy Product Offered
11.15.3 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Fujifilm Main Business Overview
11.15.5 Fujifilm Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. iPSC Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. iPSC Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Human iPSCs
Table 4. Major Players of Mouse iPSCs
Table 5. iPSC Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global iPSC Therapy Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Hospitals
Table 9. Major Players of Biotech Firms
Table 10. Major Players of Research Institutes
Table 11. iPSC Therapy Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global iPSC Therapy Market Size by End User (2021-2026) & ($ millions)
Table 13. Global iPSC Therapy Market Size Market Share by End User (2021-2026)
Table 14. Major Players of Neural Cells
Table 15. Major Players of Cardiac Cells
Table 16. Major Players of Retinal Cells
Table 17. Major Players of Immune Cells
Table 18. iPSC Therapy Market Size CAGR by Cell Type (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global iPSC Therapy Market Size by Cell Type (2021-2026) & ($ millions)
Table 20. Global iPSC Therapy Market Size Market Share by Cell Type (2021-2026)
Table 21. iPSC Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 23. Global iPSC Therapy Market Size Market Share by Application (2021-2026)
Table 24. Global iPSC Therapy Revenue by Player (2021-2026) & ($ millions)
Table 25. Global iPSC Therapy Revenue Market Share by Player (2021-2026)
Table 26. iPSC Therapy Key Players Head office and Products Offered
Table 27. iPSC Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global iPSC Therapy Market Size by Region (2021-2026) & ($ millions)
Table 31. Global iPSC Therapy Market Size Market Share by Region (2021-2026)
Table 32. Global iPSC Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global iPSC Therapy Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas iPSC Therapy Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas iPSC Therapy Market Size Market Share by Country (2021-2026)
Table 36. Americas iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas iPSC Therapy Market Size Market Share by Type (2021-2026)
Table 38. Americas iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas iPSC Therapy Market Size Market Share by Application (2021-2026)
Table 40. APAC iPSC Therapy Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC iPSC Therapy Market Size Market Share by Region (2021-2026)
Table 42. APAC iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe iPSC Therapy Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe iPSC Therapy Market Size Market Share by Country (2021-2026)
Table 46. Europe iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa iPSC Therapy Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of iPSC Therapy
Table 52. Key Market Challenges & Risks of iPSC Therapy
Table 53. Key Industry Trends of iPSC Therapy
Table 54. Global iPSC Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global iPSC Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global iPSC Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global iPSC Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Fujifilm Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 59. Fujifilm iPSC Therapy Product Offered
Table 60. Fujifilm iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Fujifilm Main Business
Table 62. Fujifilm Latest Developments
Table 63. Ncardia Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 64. Ncardia iPSC Therapy Product Offered
Table 65. Ncardia iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Ncardia Main Business
Table 67. Ncardia Latest Developments
Table 68. Sumitomo Dainippon Pharma Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 69. Sumitomo Dainippon Pharma iPSC Therapy Product Offered
Table 70. Sumitomo Dainippon Pharma iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Sumitomo Dainippon Pharma Main Business
Table 72. Sumitomo Dainippon Pharma Latest Developments
Table 73. Astellas Pharma Inc Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 74. Astellas Pharma Inc iPSC Therapy Product Offered
Table 75. Astellas Pharma Inc iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Astellas Pharma Inc Main Business
Table 77. Astellas Pharma Inc Latest Developments
Table 78. Fate Therapeutics, Inc Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 79. Fate Therapeutics, Inc iPSC Therapy Product Offered
Table 80. Fate Therapeutics, Inc iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Fate Therapeutics, Inc Main Business
Table 82. Fate Therapeutics, Inc Latest Developments
Table 83. Pluricell Biotech Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 84. Pluricell Biotech iPSC Therapy Product Offered
Table 85. Pluricell Biotech iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Pluricell Biotech Main Business
Table 87. Pluricell Biotech Latest Developments
Table 88. Cell Inspire Biotechnology Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 89. Cell Inspire Biotechnology iPSC Therapy Product Offered
Table 90. Cell Inspire Biotechnology iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Cell Inspire Biotechnology Main Business
Table 92. Cell Inspire Biotechnology Latest Developments
Table 93. ReproCELL Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 94. ReproCELL iPSC Therapy Product Offered
Table 95. ReproCELL iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. ReproCELL Main Business
Table 97. ReproCELL Latest Developments
Table 98. Thermo Fisher Scientific Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 99. Thermo Fisher Scientific iPSC Therapy Product Offered
Table 100. Thermo Fisher Scientific iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Thermo Fisher Scientific Main Business
Table 102. Thermo Fisher Scientific Latest Developments
Table 103. Sartorius Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 104. Sartorius iPSC Therapy Product Offered
Table 105. Sartorius iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Sartorius Main Business
Table 107. Sartorius Latest Developments
Table 108. Bio-techne Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 109. Bio-techne iPSC Therapy Product Offered
Table 110. Bio-techne iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Bio-techne Main Business
Table 112. Bio-techne Latest Developments
Table 113. Lonza Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 114. Lonza iPSC Therapy Product Offered
Table 115. Lonza iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Lonza Main Business
Table 117. Lonza Latest Developments
Table 118. Takara Bio Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 119. Takara Bio iPSC Therapy Product Offered
Table 120. Takara Bio iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Takara Bio Main Business
Table 122. Takara Bio Latest Developments
Table 123. STEMCELL Technologies Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 124. STEMCELL Technologies iPSC Therapy Product Offered
Table 125. STEMCELL Technologies iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. STEMCELL Technologies Main Business
Table 127. STEMCELL Technologies Latest Developments
Table 128. Fujifilm Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 129. Fujifilm iPSC Therapy Product Offered
Table 130. Fujifilm iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Fujifilm Main Business
Table 132. Fujifilm Latest Developments
Table 1. iPSC Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. iPSC Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Human iPSCs
Table 4. Major Players of Mouse iPSCs
Table 5. iPSC Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global iPSC Therapy Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Hospitals
Table 9. Major Players of Biotech Firms
Table 10. Major Players of Research Institutes
Table 11. iPSC Therapy Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global iPSC Therapy Market Size by End User (2021-2026) & ($ millions)
Table 13. Global iPSC Therapy Market Size Market Share by End User (2021-2026)
Table 14. Major Players of Neural Cells
Table 15. Major Players of Cardiac Cells
Table 16. Major Players of Retinal Cells
Table 17. Major Players of Immune Cells
Table 18. iPSC Therapy Market Size CAGR by Cell Type (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global iPSC Therapy Market Size by Cell Type (2021-2026) & ($ millions)
Table 20. Global iPSC Therapy Market Size Market Share by Cell Type (2021-2026)
Table 21. iPSC Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 23. Global iPSC Therapy Market Size Market Share by Application (2021-2026)
Table 24. Global iPSC Therapy Revenue by Player (2021-2026) & ($ millions)
Table 25. Global iPSC Therapy Revenue Market Share by Player (2021-2026)
Table 26. iPSC Therapy Key Players Head office and Products Offered
Table 27. iPSC Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global iPSC Therapy Market Size by Region (2021-2026) & ($ millions)
Table 31. Global iPSC Therapy Market Size Market Share by Region (2021-2026)
Table 32. Global iPSC Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global iPSC Therapy Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas iPSC Therapy Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas iPSC Therapy Market Size Market Share by Country (2021-2026)
Table 36. Americas iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas iPSC Therapy Market Size Market Share by Type (2021-2026)
Table 38. Americas iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas iPSC Therapy Market Size Market Share by Application (2021-2026)
Table 40. APAC iPSC Therapy Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC iPSC Therapy Market Size Market Share by Region (2021-2026)
Table 42. APAC iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe iPSC Therapy Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe iPSC Therapy Market Size Market Share by Country (2021-2026)
Table 46. Europe iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa iPSC Therapy Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa iPSC Therapy Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa iPSC Therapy Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of iPSC Therapy
Table 52. Key Market Challenges & Risks of iPSC Therapy
Table 53. Key Industry Trends of iPSC Therapy
Table 54. Global iPSC Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global iPSC Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global iPSC Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global iPSC Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Fujifilm Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 59. Fujifilm iPSC Therapy Product Offered
Table 60. Fujifilm iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Fujifilm Main Business
Table 62. Fujifilm Latest Developments
Table 63. Ncardia Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 64. Ncardia iPSC Therapy Product Offered
Table 65. Ncardia iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Ncardia Main Business
Table 67. Ncardia Latest Developments
Table 68. Sumitomo Dainippon Pharma Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 69. Sumitomo Dainippon Pharma iPSC Therapy Product Offered
Table 70. Sumitomo Dainippon Pharma iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Sumitomo Dainippon Pharma Main Business
Table 72. Sumitomo Dainippon Pharma Latest Developments
Table 73. Astellas Pharma Inc Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 74. Astellas Pharma Inc iPSC Therapy Product Offered
Table 75. Astellas Pharma Inc iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Astellas Pharma Inc Main Business
Table 77. Astellas Pharma Inc Latest Developments
Table 78. Fate Therapeutics, Inc Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 79. Fate Therapeutics, Inc iPSC Therapy Product Offered
Table 80. Fate Therapeutics, Inc iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Fate Therapeutics, Inc Main Business
Table 82. Fate Therapeutics, Inc Latest Developments
Table 83. Pluricell Biotech Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 84. Pluricell Biotech iPSC Therapy Product Offered
Table 85. Pluricell Biotech iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Pluricell Biotech Main Business
Table 87. Pluricell Biotech Latest Developments
Table 88. Cell Inspire Biotechnology Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 89. Cell Inspire Biotechnology iPSC Therapy Product Offered
Table 90. Cell Inspire Biotechnology iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Cell Inspire Biotechnology Main Business
Table 92. Cell Inspire Biotechnology Latest Developments
Table 93. ReproCELL Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 94. ReproCELL iPSC Therapy Product Offered
Table 95. ReproCELL iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. ReproCELL Main Business
Table 97. ReproCELL Latest Developments
Table 98. Thermo Fisher Scientific Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 99. Thermo Fisher Scientific iPSC Therapy Product Offered
Table 100. Thermo Fisher Scientific iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Thermo Fisher Scientific Main Business
Table 102. Thermo Fisher Scientific Latest Developments
Table 103. Sartorius Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 104. Sartorius iPSC Therapy Product Offered
Table 105. Sartorius iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Sartorius Main Business
Table 107. Sartorius Latest Developments
Table 108. Bio-techne Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 109. Bio-techne iPSC Therapy Product Offered
Table 110. Bio-techne iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Bio-techne Main Business
Table 112. Bio-techne Latest Developments
Table 113. Lonza Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 114. Lonza iPSC Therapy Product Offered
Table 115. Lonza iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Lonza Main Business
Table 117. Lonza Latest Developments
Table 118. Takara Bio Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 119. Takara Bio iPSC Therapy Product Offered
Table 120. Takara Bio iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Takara Bio Main Business
Table 122. Takara Bio Latest Developments
Table 123. STEMCELL Technologies Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 124. STEMCELL Technologies iPSC Therapy Product Offered
Table 125. STEMCELL Technologies iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. STEMCELL Technologies Main Business
Table 127. STEMCELL Technologies Latest Developments
Table 128. Fujifilm Details, Company Type, iPSC Therapy Area Served and Its Competitors
Table 129. Fujifilm iPSC Therapy Product Offered
Table 130. Fujifilm iPSC Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Fujifilm Main Business
Table 132. Fujifilm Latest Developments
LIST OF FIGURES
Figure 1. iPSC Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global iPSC Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. iPSC Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. iPSC Therapy Sales Market Share by Country/Region (2025)
Figure 8. iPSC Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global iPSC Therapy Market Size Market Share by Type in 2025
Figure 10. Global iPSC Therapy Market Size Market Share by End User in 2025
Figure 11. Global iPSC Therapy Market Size Market Share by Cell Type in 2025
Figure 12. iPSC Therapy in Academic Research
Figure 13. Global iPSC Therapy Market: Academic Research (2021-2026) & ($ millions)
Figure 14. iPSC Therapy in Drug Development and Discovery
Figure 15. Global iPSC Therapy Market: Drug Development and Discovery (2021-2026) & ($ millions)
Figure 16. iPSC Therapy in Toxicity Screening
Figure 17. Global iPSC Therapy Market: Toxicity Screening (2021-2026) & ($ millions)
Figure 18. iPSC Therapy in Regenerative Medicine
Figure 19. Global iPSC Therapy Market: Regenerative Medicine (2021-2026) & ($ millions)
Figure 20. iPSC Therapy in Others
Figure 21. Global iPSC Therapy Market: Others (2021-2026) & ($ millions)
Figure 22. Global iPSC Therapy Market Size Market Share by Application in 2025
Figure 23. Global iPSC Therapy Revenue Market Share by Player in 2025
Figure 24. Global iPSC Therapy Market Size Market Share by Region (2021-2026)
Figure 25. Americas iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 26. APAC iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 27. Europe iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 29. Americas iPSC Therapy Value Market Share by Country in 2025
Figure 30. United States iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC iPSC Therapy Market Size Market Share by Region in 2025
Figure 35. APAC iPSC Therapy Market Size Market Share by Type (2021-2026)
Figure 36. APAC iPSC Therapy Market Size Market Share by Application (2021-2026)
Figure 37. China iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. India iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe iPSC Therapy Market Size Market Share by Country in 2025
Figure 44. Europe iPSC Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Europe iPSC Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Germany iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. France iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. UK iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa iPSC Therapy Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa iPSC Therapy Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa iPSC Therapy Market Size Market Share by Application (2021-2026)
Figure 54. Egypt iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 60. APAC iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 61. Europe iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 63. United States iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 64. Canada iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 65. Mexico iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 66. Brazil iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 67. China iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 68. Japan iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 69. Korea iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 71. India iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 72. Australia iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 73. Germany iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 74. France iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 75. UK iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 76. Italy iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 77. Russia iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 78. Egypt iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 79. South Africa iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 80. Israel iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 81. Turkey iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 82. Global iPSC Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global iPSC Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 1. iPSC Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global iPSC Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. iPSC Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. iPSC Therapy Sales Market Share by Country/Region (2025)
Figure 8. iPSC Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global iPSC Therapy Market Size Market Share by Type in 2025
Figure 10. Global iPSC Therapy Market Size Market Share by End User in 2025
Figure 11. Global iPSC Therapy Market Size Market Share by Cell Type in 2025
Figure 12. iPSC Therapy in Academic Research
Figure 13. Global iPSC Therapy Market: Academic Research (2021-2026) & ($ millions)
Figure 14. iPSC Therapy in Drug Development and Discovery
Figure 15. Global iPSC Therapy Market: Drug Development and Discovery (2021-2026) & ($ millions)
Figure 16. iPSC Therapy in Toxicity Screening
Figure 17. Global iPSC Therapy Market: Toxicity Screening (2021-2026) & ($ millions)
Figure 18. iPSC Therapy in Regenerative Medicine
Figure 19. Global iPSC Therapy Market: Regenerative Medicine (2021-2026) & ($ millions)
Figure 20. iPSC Therapy in Others
Figure 21. Global iPSC Therapy Market: Others (2021-2026) & ($ millions)
Figure 22. Global iPSC Therapy Market Size Market Share by Application in 2025
Figure 23. Global iPSC Therapy Revenue Market Share by Player in 2025
Figure 24. Global iPSC Therapy Market Size Market Share by Region (2021-2026)
Figure 25. Americas iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 26. APAC iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 27. Europe iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa iPSC Therapy Market Size 2021-2026 ($ millions)
Figure 29. Americas iPSC Therapy Value Market Share by Country in 2025
Figure 30. United States iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC iPSC Therapy Market Size Market Share by Region in 2025
Figure 35. APAC iPSC Therapy Market Size Market Share by Type (2021-2026)
Figure 36. APAC iPSC Therapy Market Size Market Share by Application (2021-2026)
Figure 37. China iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. India iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe iPSC Therapy Market Size Market Share by Country in 2025
Figure 44. Europe iPSC Therapy Market Size Market Share by Type (2021-2026)
Figure 45. Europe iPSC Therapy Market Size Market Share by Application (2021-2026)
Figure 46. Germany iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. France iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. UK iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa iPSC Therapy Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa iPSC Therapy Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa iPSC Therapy Market Size Market Share by Application (2021-2026)
Figure 54. Egypt iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries iPSC Therapy Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 60. APAC iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 61. Europe iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 63. United States iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 64. Canada iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 65. Mexico iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 66. Brazil iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 67. China iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 68. Japan iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 69. Korea iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 71. India iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 72. Australia iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 73. Germany iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 74. France iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 75. UK iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 76. Italy iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 77. Russia iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 78. Egypt iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 79. South Africa iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 80. Israel iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 81. Turkey iPSC Therapy Market Size 2027-2032 ($ millions)
Figure 82. Global iPSC Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global iPSC Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries iPSC Therapy Market Size 2027-2032 ($ millions)
